ANGELA D. KUTSUNIS DO
Prescription History 1710035613
Family Medicine in San Diego, CA

Active since January 08, 2007PECOS Enrolled
4647 ZION AVE, SAN DIEGO, CA 92120(619) 528-5000 Get Directions

NPPES record last updated: November 29, 2021. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ANGELA D. KUTSUNIS DO, an active Family Medicine specialist practicing in San Diego, CA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 13 documented patient claims. Among these therapy options, the most frequently utilized medication is Paxlovid, which accounts for 13 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
13
Total Claims
13
30-Day Fills
Paxlovid
Most Prescribed · 13 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by ANGELA D. KUTSUNIS DO in 2024, with prescription volumes, average cost per fill, and CA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other CA PrescribersVs. CA Avg
PaxlovidNirmatrelvir/Ritonavir13$0.00▼ below CA avg▼ Less than typical

About Paxlovid: This combination of nirmatrelvir and ritonavir is used to treat coronavirus disease (COVID-19) in people who have mild to moderate symptoms and have a high risk for COVID-19 complications. Show more ▾

It helps people who have COVID-19 to stay out of the hospital. It is not for use by people who are hospitalized due to COVID-19. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases ("boosts") the levels of nirmatrelvir. This helps nirmatrelvir work better. This medication works by stopping the coronavirus from growing. It cannot be used to prevent COVID-19.

In 2024, this provider wrote 13 Medicare prescriptions for Paxlovid, about half the volume of the typical California prescriber of this medication (24.2).

How often this provider prescribes it

This provider
13
CA average
24.2

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$0.00
CA average
$42.82

This provider's average cost per fill is below the CA average for this medication.

13
30-Day Fills
standardized to 30-day supplies
65
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average CA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the CA average cost per fill.

About this data. The prescription history for ANGELA D. KUTSUNIS DO is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family Medicine prescribing approach at this San Diego, CA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.